Anifrolumab
- Generic Name
- Anifrolumab
- Brand Names
- Saphnelo
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 1326232-46-5
- Unique Ingredient Identifier
- 38RL9AE51Q
- Background
Anifrolumab, or MEDI-546, is a type 1 interferon receptor (IFNAR) inhibiting IgG1κ monoclonal antibody indicated in the treatment of adults with moderate to severe systemic lupus erythematosus. The standard therapy for systemic lupus erythematosus consists of antimalarials like hydroxychloroquine, glucocorticoids like dexamethasone, and disease modifying ant...
- Indication
Anifrolumab is indicated in the treatment of adults with moderate to severe systemic lupus erythematosus.
- Associated Conditions
- Moderate Systemic Lupus Erythematosus (SLE), Severe Systemic Lupus Erythematosus (SLE)
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath